Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

Cancer Cell

Volumn 8, Issue 5, 2005, Pages 381-392

  Lim, Kian Huat ^a   Counter, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MICROENVIRONMENT; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALIA;

EID: 27644556527     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.10.014     Document Type: Article

References (40)

1. M.A. Bender, T.D. Palmer, R.E. Gelinas, and A.D. Miller Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region J. Virol. 61 1987 1639 1646
2. G. Bergers, and L.E. Benjamin Tumorigenesis and the angiogenic switch Nat. Rev. Cancer 3 2003 401 410
3. J.L. Bos ras oncogenes in human cancer: a review Cancer Res. 49 1989 4682 4689
4. T.R. Brummelkamp, R. Bernards, and R. Agami Stable suppression of tumorigenicity by virus-mediated RNA interference Cancer Cell 2 2002 243 247
5. K. Burridge, and K. Wennerberg Rho and Rac take center stage Cell 116 2004 167 179
6. L. Chin, A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, and H. Zhou Essential role for oncogenic Ras in tumour maintenance Nature 400 1999 468 472
7. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
8. M. Dajee, M. Tarutani, H. Deng, T. Cai, and P.A. Khavari Epidermal Ras blockade demonstrates spatially localized Ras promotion of proliferation and inhibition of differentiation Oncogene 21 2002 1527 1538
9. H.F. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315 1986 1650 1659
10. L.A. Feig Ral-GTPases: approaching their 15 minutes of fame Trends Cell Biol. 13 2003 419 425
11. S. Giuriato, K. Rabin, A.C. Fan, C.M. Shachaf, and D.W. Felsher Conditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer Semin. Cancer Biol. 14 2004 3 11
12. W.C. Hahn, C.M. Counter, A.S. Lundberg, R.L. Beijersbergen, M.W. Brooks, and R.A. Weinberg Creation of human tumour cells with defined genetic elements Nature 400 1999 464 468
13. N.M. Hamad, J.H. Elconin, A.E. Karnoub, W. Bai, J.N. Rich, R.T. Abraham, C.J. Der, and C.M. Counter Distinct requirements for Ras oncogenesis in human versus mouse cells Genes Dev. 16 2002 2045 2057
14. A.L. Harris Hypoxia - a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47
15. N. Ikehara, S. Semba, M. Sakashita, N. Aoyama, M. Kasuga, and H. Yokozaki BRAF mutation associated with dysregulation of apoptosis in human colorectal neoplasms Int. J. Cancer 115 2005 943 950
16. G. Kulik, A. Klippel, and M.J. Weber Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt Mol. Cell. Biol. 17 1997 1595 1606
17. K.H. Lim, and C.M. Counter Leveling the playing field Mol. Cell 15 2004 491 492
18. K.H. Lim, A.T. Baines, J.J. Fiordalisi, M. Shipitsin, L.A. Feig, A.D. Cox, C.J. Der, and C.M. Counter Activation of RalA is critical for Ras-induced tumorigenesis of human cells Cancer Cell 7 2005 533 545
19. J. Luo, B.D. Manning, and L.C. Cantley Targeting the PI3K-Akt pathway in human cancer: Rationale and promise Cancer Cell 4 2003 257 262
20. S.J. Mansour, W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Vande Woude, and N.G. Ahn Transformation of mammalian cells by constitutively active MAP kinase kinase Science 265 1994 966 970
21. D.R. McFarlin, and M.N. Gould Rat mammary carcinogenesis induced by in situ expression of constitutive Raf kinase activity is prevented by tethering Raf to the plasma membrane Carcinogenesis 24 2003 1149 1153
22. D.R. McFarlin, M.J. Lindstrom, and M.N. Gould Affinity with Raf is sufficient for Ras to efficiently induce rat mammary carcinomas Carcinogenesis 24 2003 99 105
23. D.K. Morrison, and R.E. Cutler The complexity of Raf-1 regulation Curr. Opin. Cell Biol. 9 1997 174 179
24. M.M. Mueller, and N.E. Fusenig Friends or foes - bipolar effects of the tumour stroma in cancer Nat. Rev. Cancer 4 2004 839 849
25. O'Hayer, K.M., and Counter, C.M. (2005). A genetically defined normal human somatic cell system to study ras oncogenesis in vitro and in vivo. In Methods in Enzymology, Volume 407, Regulators and Effectors of Small GTPases, Part H: Ras Family, W.E. Balch, C.J. Der, A. Hall, eds. (San Diego, CA: Academic Press), in press.
26. S. Pelengaris, M. Khan, and G.I. Evan Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression Cell 109 2002 321 334
27. A. Rangarajan, and R.A. Weinberg Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice Nat. Rev. Cancer 3 2003 952 959
28. A. Rangarajan, S.J. Hong, A. Gifford, and R.A. Weinberg Species- and cell type-specific requirements for cellular transformation Cancer Cell 6 2004 171 183
29. P. Rodriguez-Viciana, P.H. Warne, A. Khwaja, B.M. Marte, D. Pappin, P. Das, M.D. Waterfield, A. Ridley, and J. Downward Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras Cell 89 1997 457 467
30. J.M. Shields, K. Pruitt, A. McFall, A. Shaub, and C.J. Der Understanding Ras: 'it ain't over 'til it's over' Trends Cell Biol. 10 2000 147 154
31. A. Singh, A.E. Karnoub, T.R. Palmby, E. Lengyel, J. Sondek, and C.J. Der Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation Oncogene 23 2004 9369 9380
32. V.P. Stanton, D.W. Nichols, A.P. Laudano, and G.M. Cooper Definition of the human raf amino-terminal regulatory region by deletion mutagenesis Mol. Cell. Biol. 9 1989 639 647
33. M. Tarutani, T. Cai, M. Dajee, and P.A. Khavari Inducible activation of Ras and Raf in adult epidermis Cancer Res. 63 2003 319 323
34. A.S. Ulku, and C.J. Der Ras signaling, deregulation of gene expression and oncogenesis Cancer Treat. Res. 115 2003 189 208
35. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat. Rev. Cancer 2 2002 489 501
36. M.A. White, C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M.H. Wigler Multiple Ras functions can contribute to mammalian cell transformation Cell 80 1995 533 541
37. M.A. White, T. Vale, J.H. Camonis, E. Schaefer, and M.H. Wigler A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation J. Biol. Chem. 271 1996 16439 16442
38. R.M. Wolthuis, N.D. de Ruiter, R.H. Cool, and J.L. Bos Stimulation of gene induction and cell growth by the Ras effector Rlf EMBO J. 16 1997 6748 6761
39. R.M. Wolthuis, B. Franke, M. van Triest, B. Bauer, R.H. Cool, J.H. Camonis, J.W. Akkerman, and J.L. Bos Activation of the small GTPase Ral in platelets Mol. Cell. Biol. 18 1998 2486 2491
40. J. Yan, S. Roy, A. Apolloni, A. Lane, and J.F. Hancock Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase J. Biol. Chem. 273 1998 24052 24056